collaborations

View All

Delveinsight
Are you ready to embrace Gene Therapy?

Gene Therapy: The “Big Value” Market! Gene therapy has been under scientific research for over 2 decades, but viable therapies have yet to gain commercial acceptance due to safety and delivery-related issues. However, Pfizer’s move and some other recent developments in the industry suggest that the therapy may be ...

Find More

Delveinsight
DelveInsight’s Ophthalmologic disorders based Gene Therapy Reports

Gene Therapy: Eye for the cure! Recent technical advances have led to the demonstration of the molecular basis of various ocular diseases. Gene transfer into ocular tissues has been demonstrated with growing functional success and may develop into a new therapeutic tool for clinical ophthalmology.  There are pr...

Find More

Delveinsight
DelveInsight’s Hematological disorders based Gene Therapy Reports

Gene Therapy to “target” Hematological disorders! About Hematological disorders Hematology is the study of blood in health and disease. It includes problems with the red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting (h...

Find More

Delveinsight
DelveInsight’s Respiratory disorders based Gene Therapy Reports

Gene Therapy’s “expanding” role in Respiratory disorders! About Respiratory disorders Respiratory disorders encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles...

Find More

Delveinsight
DelveInsight’s Immunology based Gene Therapy Reports

Gene Therapy: The “Hope” for Immunologic disorders! About Immunologic disorders Immunological disorders are a dysfunction of the immune system. These disorders cause abnormally low activity or overactivity of the immune system. In cases of immune system overactivity, the body attacks and damages its own tissues. T...

Find More

Delveinsight
DelveInsight’s Cardiovascular disorders based Gene Therapy Reports

Gene Therapy to “heal” Cardiovascular disorders! Coronary artery disease, heart failure, and cardiac arrhythmias are major causes of morbidity and mortality in the developed countries. Pharmacologic drugs and device therapies have multiple limitations, and there exists an unmet need for improved clinical outcomes ...

Find More

Delveinsight
DelveInsight’s Musculoskeletal disorders based Gene Therapy Reports

Gene Therapy at the “Forefront” for Musculoskeletal disorders! About Musculoskeletal disorders Musculoskeletal disorders (MSDs) are injuries or pain in the body's joints, ligaments, muscles, nerves, tendons, and structures that support limbs, neck and back. MSDs are degenerative diseases and inflammatory condition...

Find More

Delveinsight
DelveInsight’s Metabolic disorders based Gene Therapy Reports

Gene Therapy to “reverse” Metabolic disorders! Metabolic disorders are collectively common, frequently severe and in many instances difficult or impossible to treat. Accordingly, there is a compelling need to explore novel therapeutic modalities, including gene therapy, and examine multiple phenotypes where the ri...

Find More

Delveinsight
DelveInsight’s Infectious disorders based Gene Therapy Reports

Gene Therapy to “block” Infectious disorders! Until recently, the idea of genetically modifying a person’s immune system to make it resistant to infectious disorders like HIV was considered so impractical that it belonged in the realm of science fiction. However over the past year or so, an accumulation of new dat...

Find More

Delveinsight
DelveInsight’s Gastrointestinal based Gene Therapy Reports

Gene Therapy: The “Promise” to cure Gastrointestinal disorders! About Gastrointestinal disorders Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestions, the liver, gallblad...

Find More